Printer Friendly

LIFECORE BIOMEDICAL ANNOUNCES EXTENSION OF ALCON SUPPLY AGREEMENT

 LIFECORE BIOMEDICAL ANNOUNCES EXTENSION OF ALCON SUPPLY AGREEMENT
 CHASKA, Minn., July 20 /PRNewswire/ -- Lifecore Biomedical, Inc. (NASDAQ: LCBM) today announced the amendment of its supply agreement with Alcon Surgical, Inc. (ALCON) of Fort Worth, Texas. The amendment extends the term for the non-exclusive supply of Lifecore's sodium hyaluronate to Alcon through Dec. 31, 1995.
 The revised agreement provides for the purchase of minimum annual hyaluronate quantities from Lifecore aggregating approximately $8.8 million over the remaining three and one-half year term of the contract through Dec. 31, 1995.
 The company's relationship with Alcon and its predecessors dates back to 1983 when Lifecore's sodium hyaluronate was first specified as a raw material component of Alcon's Viscoat(R), a viscoelastic eye surgery product used primarily in the implantation of intraocular lenses in patients with cataracts.
 Lifecore develops, manufactures and markets sterile medical devices for a variety of surgical applications, through both direct sales and OEM supplier relationships.
 -0- 7/20/92
 /CONTACT: Maggie P. Knack or John C. Heinmiller, 612-368-4300, both of Lifecore Biomedical/
 (LCBM) CO: Lifecore Biomedical; Alcon Surgical ST: Minnesota IN: MTC SU: JVN


MA -- MN005 -- 0681 07/20/92 11:08 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 20, 1992
Words:193
Previous Article:BEMIS EARNINGS PER SHARE INCREASE 20 PERCENT
Next Article:AMEX TO OPEN OPTIONS TRADING ON ROYAL APPLIANCE MANUFACTURING COMPANY
Topics:


Related Articles
LIFECORE REPORTS SECOND QUARTER RESULTS; POTENTIAL CONTRACT RENEWAL
LIFECORE BIOMEDICAL REPORTS THIRD QUARTER RESULTS
LIFECORE BIOMEDICAL REPORTS FISCAL 1992 RESULTS
LIFECORE BIOMEDICAL REPORTS FIRST QUARTER RESULTS; INCREASED ALCON ORDER
LIFECORE SIGNS RESEARCH AGREEMENT WITH IOLAB CORPORATION
LIFECORE SIGNS LETTER OF INTENT REVISING ETHICON PRODUCT DEVELOPMENT RELATIONSHIP
LIFECORE RECEIVES 1995 PURCHASE ORDER AND CASH ADVANCE FROM ALCON; EXTENDS CONTRACT THROUGH 1998
LIFECORE SIGNS HYALURONATE SUPPLY AGREEMENT WITH CHEMEDICA S.A.
LIFECORE TO SUPPLY MENTOR WITH OPHTHALMIC VISCOELASTIC SOLUTION
LIFECORE AND CHIRON VISION STRENGTHEN SUPPLY RELATIONSHIP

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters